135 related articles for article (PubMed ID: 10663665)
1. [Reactive lymphoid nodule or malignant lymphoma. A brief guideline for the differential diagnosis of bone marrow infiltrates in non-Hodgkin lymphomas].
Thiele J; Kvasnicka HM
Pathologe; 2000 Jan; 21(1):16-23. PubMed ID: 10663665
[TBL] [Abstract][Full Text] [Related]
2. Focal lymphoid aggregates (nodules) in bone marrow biopsies: differentiation between benign hyperplasia and malignant lymphoma--a practical guideline.
Thiele J; Zirbes TK; Kvasnicka HM; Fischer R
J Clin Pathol; 1999 Apr; 52(4):294-300. PubMed ID: 10474523
[TBL] [Abstract][Full Text] [Related]
3. Lymphoid infiltrates in B cell non Hodgkin's lymphoma: comparing nuclear characteristics between lymph node and bone marrow; and evaluating diagnostic features of bone marrow infiltrates in paraffin embedded tissues.
Deverell MH; Best E; Salisbury JR
Anal Cell Pathol; 1997; 14(1):1-7. PubMed ID: 9283039
[TBL] [Abstract][Full Text] [Related]
4. [Differential "lymphoid cell infiltrates" diagnosis in bone marrow].
Thiele J
Pathologe; 1995 Mar; 16(2):106-19. PubMed ID: 7761356
[TBL] [Abstract][Full Text] [Related]
5. Benign lymphoid aggregates in the bone marrow: distribution patterns of B and T lymphocytes.
Naemi K; Brynes RK; Reisian N; Johnston A; Dhillon R; Walavalkar V; Zhao X; Rezk SA
Hum Pathol; 2013 Apr; 44(4):512-20. PubMed ID: 23063505
[TBL] [Abstract][Full Text] [Related]
6. The immunologic characterization of 40 extranodal lymphoid infiltrates: usefulness in distinguishing between benign pseudolymphoma and malignant lymphoma.
Knowles DM; Halper JP; Jakobiec FA
Cancer; 1982 Jun; 49(11):2321-35. PubMed ID: 6804083
[TBL] [Abstract][Full Text] [Related]
7. Incidence and histological features of bone marrow involvement in malignant lymphomas.
Lambertenghi-Deliliers G; Annaloro C; Soligo D; Oriani A; Pozzoli E; Quirici N; Luksch R; Polli EE
Ann Hematol; 1992 Aug; 65(2):61-5. PubMed ID: 1324741
[TBL] [Abstract][Full Text] [Related]
8. Lymphoid aggregates in bone marrow mimic residual lymphoma after rituximab therapy for non-Hodgkin lymphoma.
Douglas VK; Gordon LI; Goolsby CL; White CA; Peterson LC
Am J Clin Pathol; 1999 Dec; 112(6):844-53. PubMed ID: 10587708
[TBL] [Abstract][Full Text] [Related]
9. Bone Marrow Involvement in Patients With Nodular Lymphocyte Predominant Hodgkin Lymphoma.
Agbay RLMC; Loghavi S; Zuo Z; Fayad L; Dabaja B; Medeiros LJ; Khoury JD
Am J Surg Pathol; 2018 Apr; 42(4):492-499. PubMed ID: 29309302
[TBL] [Abstract][Full Text] [Related]
10. Immunohistocytochemical correlation of DAP IV-CD 26 reactivity with immunologic markers of lymphocyte activation in human lymphoid tissues.
Cozzi M; Gloghini A; Volpe R; Carbone A
Br J Haematol; 1990 Jul; 75(3):325-32. PubMed ID: 1974815
[TBL] [Abstract][Full Text] [Related]
11. Reticulin fibre content of bone marrow infiltrates of malignant non-Hodgkin's lymphomas (B-cell type, low malignancy)--a morphometric evaluation before and after therapy.
Thiele J; Langohr J; Skorupka M; Fischer R
Virchows Arch A Pathol Anat Histopathol; 1990; 417(6):485-92. PubMed ID: 2125386
[TBL] [Abstract][Full Text] [Related]
12. Expression of activation-induced cytidine deaminase in malignant lymphomas infiltrating the bone marrow.
Engels K; Jungnickel B; Tobollik S; Hansmann ML; Kriener S; Willenbrock K
Appl Immunohistochem Mol Morphol; 2008 Dec; 16(6):521-9. PubMed ID: 18776814
[TBL] [Abstract][Full Text] [Related]
13. Discordant morphologic features in bone marrow involvement by malignant lymphomas: use of gene rearrangement patterns for diagnosis.
Crisan D; Mattson JC
Am J Hematol; 1995 Aug; 49(4):299-309. PubMed ID: 7639275
[TBL] [Abstract][Full Text] [Related]
14. [Non-Hodgkin's lymphoma. Cytology and cytochemistry].
Schwarze EW
Veroff Pathol; 1986; 123():1-241. PubMed ID: 3518274
[TBL] [Abstract][Full Text] [Related]
15. Distribution of lymphocytes with interleukin-2 receptors (TAC antigens) in reactive lymphoproliferative processes, Hodgkin's disease, and non-Hodgkin's lymphomas. An immunohistologic study of 300 cases.
Sheibani K; Winberg CD; van de Velde S; Blayney DW; Rappaport H
Am J Pathol; 1987 Apr; 127(1):27-37. PubMed ID: 3105322
[TBL] [Abstract][Full Text] [Related]
16. [Immunocytologic diagnosis of leukemia and lymphoma: monoclonal antibodies in the differential diagnosis of hematologic neoplasms].
Huber H; Gattringer C; Thaler J; Peschel C
Behring Inst Mitt; 1985 Dec; (78):83-117. PubMed ID: 3914283
[TBL] [Abstract][Full Text] [Related]
17. Fine needle aspiration cytology and immunocytochemistry in the diagnosis of lymphoid lesions of the thyroid gland.
Tani E; Skoog L
Acta Cytol; 1989; 33(1):48-52. PubMed ID: 2521756
[TBL] [Abstract][Full Text] [Related]
18. Bone marrow lymphoid aggregates in malignant lymphomas.
Dominis M; Pesut A; Borovecki A; Marusic-Vrsalovic M; Kusec R
Croat Med J; 2005 Jun; 46(3):410-6. PubMed ID: 15861520
[TBL] [Abstract][Full Text] [Related]
19. Leu-22: a preferential marker for T-lymphocytes in paraffin sections. Staining profile in T- and B-cell lymphomas, Hodgkin's disease, other lymphoproliferative disorders, myeloproliferative diseases, and various neoplastic processes.
Said JW; Stoll PN; Shintaku P; Bindl JM; Butmarc JR; Pinkus GS
Am J Clin Pathol; 1989 May; 91(5):542-9. PubMed ID: 2785753
[TBL] [Abstract][Full Text] [Related]
20. Bone marrow manifestations of peripheral T-cell lymphoma. A study of 30 cases.
Hanson CA; Brunning RD; Gajl-Peczalska KJ; Frizzera G; McKenna RW
Am J Clin Pathol; 1986 Oct; 86(4):449-60. PubMed ID: 3490173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
